These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26562402)

  • 41. Adding double carbapenem therapy to the armamentarium against carbapenem-resistant Enterobacteriaceae bloodstream infections.
    White BP; Patel S; Tsui J; Chastain DB
    Infect Dis (Lond); 2019 Mar; 51(3):161-167. PubMed ID: 30663923
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Control of simultaneous outbreaks of carbapenemase-producing enterobacteriaceae and extensively drug-resistant Acinetobacter baumannii infection in an intensive care unit using interventions promoted in the Centers for Disease Control and Prevention 2012 carbapenemase-resistant Enterobacteriaceae Toolkit.
    Enfield KB; Huq NN; Gosseling MF; Low DJ; Hazen KC; Toney DM; Slitt G; Zapata HJ; Cox HL; Lewis JD; Kundzins JR; Mathers AJ; Sifri CD
    Infect Control Hosp Epidemiol; 2014 Jul; 35(7):810-7. PubMed ID: 24915208
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Carbapenem-resistant Enterobacteriaceae among kidney transplant recipients - insights on the risk of acquisition and CRE infection.
    Freire MP; Carvalho LB; Reusing JO; Spadão F; Lopes MIBF; Nahas WC; David-Neto E; Pierrotti LC
    Infect Dis (Lond); 2021 Jun; 53(6):430-439. PubMed ID: 33612056
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Over-treatment of carbapenemase-producing Enterobacteriaceae.
    Rihani DS; Wallace MR; Sieger BE; Waite RA; Fox M; Brown SA; Deryke CA
    Scand J Infect Dis; 2012 May; 44(5):325-9. PubMed ID: 22200121
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Potential Trajectory of Carbapenem-Resistant Enterobacteriaceae, an Emerging Threat to Health-Care Facilities, and the Impact of the Centers for Disease Control and Prevention Toolkit.
    Lee BY; Bartsch SM; Wong KF; McKinnell JA; Slayton RB; Miller LG; Cao C; Kim DS; Kallen AJ; Jernigan JA; Huang SS
    Am J Epidemiol; 2016 Mar; 183(5):471-9. PubMed ID: 26861238
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Carbapenem-Resistant Enterobacteriaceae: A Strategic Roadmap for Infection Control.
    Friedman ND; Carmeli Y; Walton AL; Schwaber MJ
    Infect Control Hosp Epidemiol; 2017 May; 38(5):580-594. PubMed ID: 28294079
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Laboratory evaluation of the CHROMagar KPC medium for identification of carbapenem-nonsusceptible Enterobacteriaceae.
    Moran Gilad J; Carmeli Y; Schwartz D; Navon-Venezia S
    Diagn Microbiol Infect Dis; 2011 Aug; 70(4):565-7. PubMed ID: 21767716
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treating infections caused by carbapenemase-producing Enterobacteriaceae.
    Tzouvelekis LS; Markogiannakis A; Piperaki E; Souli M; Daikos GL
    Clin Microbiol Infect; 2014 Sep; 20(9):862-72. PubMed ID: 24890393
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The outcome of treating ESBL infections with carbapenems vs. non carbapenem antimicrobials.
    Trivedi M; Patel V; Soman R; Rodriguez C; Singhal T
    J Assoc Physicians India; 2012 Aug; 60():28-30. PubMed ID: 23405518
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection.
    Ben-David D; Maor Y; Keller N; Regev-Yochay G; Tal I; Shachar D; Zlotkin A; Smollan G; Rahav G
    Infect Control Hosp Epidemiol; 2010 Jun; 31(6):620-6. PubMed ID: 20370465
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [KPC carbapenemases: what is at stake in clinical microbiology?].
    Cuzon G; Naas T; Nordmann P
    Pathol Biol (Paris); 2010 Feb; 58(1):39-45. PubMed ID: 19854586
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies.
    Patel G; Huprikar S; Factor SH; Jenkins SG; Calfee DP
    Infect Control Hosp Epidemiol; 2008 Dec; 29(12):1099-106. PubMed ID: 18973455
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development and Distribution of Educational Materials for Carbapenem-Resistant Enterobacteriaceae Among Acute and Long-term Care Facilities.
    Kram JJ; Borlaug G; Safdar N; Sethi A
    WMJ; 2015 Apr; 114(2):48-51. PubMed ID: 26756056
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extended-spectrum beta-lactamase-producing bacterial infections in adult solid organ transplant recipients.
    Winters HA; Parbhoo RK; Schafer JJ; Goff DA
    Ann Pharmacother; 2011 Mar; 45(3):309-16. PubMed ID: 21386016
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carbapenemase-producing organisms in solid organ transplantation.
    Wong D; van Duin D
    Curr Opin Organ Transplant; 2019 Aug; 24(4):490-496. PubMed ID: 31169529
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A national intervention to prevent the spread of carbapenem-resistant Enterobacteriaceae in Israeli post-acute care hospitals.
    Ben-David D; Masarwa S; Adler A; Mishali H; Carmeli Y; Schwaber MJ
    Infect Control Hosp Epidemiol; 2014 Jul; 35(7):802-9. PubMed ID: 24915207
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extended spectrum β-lactamase-producing Enterobacteriaceae infection in heart and lung transplant recipients and in mechanical circulatory support recipients.
    Bui KT; Mehta S; Khuu TH; Ross D; Carlson M; Leibowitz MR; Schaenman JM; Saggar R; Lynch JP; Ardehali A; Kubak BM
    Transplantation; 2014 Mar; 97(5):590-4. PubMed ID: 24162251
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antimicrobial treatment and outcomes of critically ill patients with OXA-48like carbapenemase-producing Enterobacteriaceae infections.
    Lowman W; Schleicher G
    Diagn Microbiol Infect Dis; 2015 Feb; 81(2):138-40. PubMed ID: 25497419
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical outcomes of Enterobacteriaceae infections stratified by carbapenem MICs.
    Patel TS; Nagel JL
    J Clin Microbiol; 2015 Jan; 53(1):201-5. PubMed ID: 25378572
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-beta-lactamase in a Greek University Hospital.
    Souli M; Kontopidou FV; Papadomichelakis E; Galani I; Armaganidis A; Giamarellou H
    Clin Infect Dis; 2008 Mar; 46(6):847-54. PubMed ID: 18269335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.